Product Description
Overall, the global extended dwell catheter market was valued at around $68 million in 2025. This is expected to increase over the forecast period at a CAGR of 5.8% to reach $100 million by 2032.
The full report suite on the global market for extended dwell catheters covers regional procedure volumes, market values, unit sales and ASP trends.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Extended Dwell Catheter Market Trends
Global procedure volumes for extended dwell catheters have been steadily increasing and are projected to continue expanding over the forecast period. North America accounts for the majority of procedures performed worldwide, with Western Europe representing the second-largest market. Meanwhile, emerging regions such as the Middle East and Africa are expected to post the fastest growth rates, albeit from smaller bases.
Global Extended Dwell Catheter Market Share Insights
- Teleflex’s recall of the Arrow® Endurance™ device triggered a notable structural shift in the global Extended Dwell Catheter (EDC) market. While the recall was formally initiated in the United States, Teleflex’s guidance to distributors regarding non-U.S. distribution and mandatory product return effectively resulted in the withdrawal of the device across multiple regions, reshaping the competitive landscape of the segment. Against this backdrop, Becton Dickinson (BD) emerged as the leading global EDC supplier, benefiting significantly from the recall-driven market disruption. BD’s EDC portfolio includes the AccuCath® and AccuCath® Ace, both rated for dwell times of up to 29 days. The company’s flagship 5.7 cm AccuCath® Ace, along with shorter and more cost-effective devices that resemble conventional PIVCs, positioned BD as the dominant player in the EDC segment.
- ICU Medical ranked second in the global EDC market in 2025. Its presence was reinforced by the 2022 acquisition of Smiths Medical, which had previously entered the market through Access Scientific. ICU Medical’s key offering, the Powerwand™ EDC, is a power-injectable catheter made from ChronoFlex material with BioGUARD™ technology, designed to simplify insertion compared with the modified Seldinger technique. Similar to BD, ICU Medical also expanded its market share following the Teleflex recall
- Vygon was a growing competitor in the EDC space in 2025. Its main product, Leaderflex®, provides dwell times up to 29 days and stands out as the only non-power-injectable device on the market. Offered in multiple lengths, including a shorter 6 cm option, Leaderflex gained increased attention after the Teleflex recall as hospitals and clinicians looked for safer, reliable extended dwell alternatives.
Global Extended Dwell Catheter Market Segmentation Summary
- Extended Dwell Catheter Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Region | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
